Vaccine diplomacy: China in the Global South

Art by Gabriella Turrisi

As Western countries began rolling out COVID-19 vaccines last week, the UAE became the first nation to authorize use of one of China's vaccines against the coronavirus. Beijing promises a major breakthrough towards ending the pandemic for billions of people across the developing world, but it comes with risks for China, and strings attached for its customers.


First, the good news. According to the Emiratis, China's Sinopharm vaccine is 86 percent effective, slightly less than Pfizer's and Moderna's but more than expected just weeks ago. It's relatively cheap to make and only requires refrigeration, a game-changer for developing nations that lack large-scale cold-storage facilities.

Chinese vaccine makers are looking at a revenue windfall, and poor nations that may soon be able to quickly inoculate large numbers of people won't have to wait as long as they feared to begin to rebuild their economies.

Now the bad news. Chinese officials have largely contained the coronavirus at home and don't need to immediately vaccinate as big a percentage of its citizens as the US does to return to normalcy. But they will need to find the right division of supplies between 1.4 billion Chinese and the foreign countries that Chinese companies have agreed to supply. A fresh COVID-19 outbreak inside China without full domestic immunization could deal President Xi Jinping a heavy political blow.

Indeed, logistics is a big problem. Sinopharm claims it can produce up to 1 billion doses — enough to inoculate 500 million people with two doses each — in 2021. China has four other vaccine candidates in phase III clinical trials and could technically ramp up production to more than 3 billion doses next year, but it will prioritize certain countries in Southeast Asia, Africa, and Latin America.

Then there are concerns over safety. Chinese firms haven't been as forthcoming with data on their clinical trials as their Western rivals in the global vaccine race. That doesn't mean their products are unsafe, but some countries that have agreed to test them on their own citizens are wary about the lack of transparency. If the results are less than promised or vaccinations produce serious side-effects, everybody loses.

China has much to gain from its vaccine diplomacy efforts. A successful drug could do a lot to restore global faith in China, whose reputation has been severely damaged by its cover-up of the initial COVID-19 outbreak in Wuhan. Beijing says it's offering its medicine to poor countries as a "public good" with soft loans to purchase vaccines. Meanwhile, the West is engaging in "vaccine nationalism" by inoculating their own people first and selling (most of) the rest for profit.

On the other hand, China's vaccine diplomacy targets neither the US nor Western countries. Its goal is to supply the Global South, where Beijing can exercise its "soft power" by giving developing nations access to the drugs that only 20 percent of their people would receive by the end of next year under the international COVAX Facility to ensure equitable distribution of vaccines.

However, all this largesse may come with a catch. Countless recipients of Chinese loans have fallen deep into China's debt trap. If they default, a state-owned Chinese company may take over strategic infrastructure. With the vaccines, however, Beijing has learned its lesson after suffering a backlash over its ham-fisted "PPE diplomacy" at the onset of the pandemic.

With vaccines, China is unlikely to make the ties too explicit, but will expect countries to scratch their back too by being friendly to Chinese interests, or at least not overly hostile on sensitive political issues. This is now evident in Turkey — which is already turning a blind eye to China's treatment of its fellow Turkic Uighurs in China's Xinjiang region in order to get early access to Sinovac's drug — and Indonesia, another country undergoing Sinovac clinical trials that has toned down its criticisms of China's claim to the contested South China Sea.

At the end of the day, though, developing countries don't have much choice. Many can't wait until all rich countries inoculate their way to herd immunity, and will roll the dice on a Chinese vaccine that may not be as effective or safe, but will offer some quick public health and economic relief. The full price of this option will become clear over time.

This time last year, world health experts were speculating about why Africa appeared to have escaped the worst of the global pandemic. Younger populations? Natural immunity created by exposure to past viruses? Something else?

They can stop wondering. Africa is now in the grip of a COVID emergency.

More Show less

Listen: Stanford historian Niall Ferguson joins Ian Bremmer on the GZERO World podcast to talk about the geopolitics of disaster. Throughout human history we seem to be unable to adequately prepare for catastrophes (natural or human-caused) before they strike. Why is that? And as we emerge from the greatest calamity of our lifetimes in the COVID-19 pandemic and look to the plethora of crises that climate change has and will cause, what can we do to lessen the blow?

Subscribe to the GZERO World Podcast on Apple Podcasts, Spotify, Stitcher, or your preferred podcast platform to receive new episodes as soon as they're published.

Get insights on the latest news in US politics from Jon Lieber, head of Eurasia Group's coverage of political and policy developments in Washington:

House Speaker Nancy Pelosi barred two Republican members from serving on the Jan. 6 commission. What's going on?

Well, the Jan. 6 commission was designed to be a bipartisan commission, taking input from members from Democrats and Republicans. House Minority Leader Kevin McCarthy had the opportunity to make recommendations but the Speaker of the House, Nancy Pelosi, could always veto those recommendations. In this case, she did, saying no to two members, Jim Banks and Jim Jordan, both of whom are strongly aligned with President Trump and who voted against certifying the election results in 2020. The Republicans for the most part see the Jan. 6 commission as an opportunity to score political points against them, and the Democrats say this is going to be a fair, non-biased, and nonpartisan investigation into what happened on Jan. 6, starting with a hearing next week with some of the police officers who were involved in the battle with the protesters inside the Capitol.

More Show less

In his New York Times op-ed, David Brooks says the US is facing an identity crisis — protecting liberal and progressive values at home while doing little to stop autocrats elsewhere. But has the US really abandoned its values abroad just because it's withdrawing from Afghanistan? Ian Bremmer and Eurasia Group analyst Charles Dunst take out the Red Pen to argue that the US can advance democracy without being the world's sheriff.

More Show less

When the Tokyo Olympics begin on Friday, Japan watchers will be following more than just the performance of Japan's star athletes, including tennis star Naomi Osaka. They will also be tracking the political fortunes of Prime Minister Yoshihide Suga, who is taking a big gamble by staging the event — amid a raging pandemic — in the face of strong and longstanding opposition from the Japanese public. What are the stakes for Suga, particularly with elections on the horizon? Eurasia Group senior analyst Ali Wyne explains.

More Show less

YouTube pulls Bolsonaro's rants: Google-owned YouTube pulled down a series of videos on the channel of Brazil's populist President Jair Bolsonaro, accusing him of spreading misinformation about the pandemic. YouTube removed more than a dozen clips for touting quack cures for coronavirus or claiming, in defiance of scientific experts, that masks don't reduce COVID transmissions. Last year, Twitter and Facebook also removed some content from Bolsonaro's feeds for similar reasons. But critics say that YouTube's move is too little too late, because Bolsonaro has been spreading misinformation about COVID since the pandemic began. Many Brazilians hold him personally responsible for the country's abysmal pandemic response, which has led to almost 550,000 deaths, the second worst toll in the world. Will YouTube's move change Bolsonaro's message? His weekly address to the nation, where he converses not only with government ministers but also various conspiracy theorists and loons, is broadcast on YouTube. Surely he doesn't want to risk losing that — or does he?

More Show less

Boycotts! Bans! Protests! Drugs! Think you've got gold medal knowledge about politics at the Olympics? Test what you know with this special Tokyo Olympics Quiz. And to stay current on all the latest political stories at the Games and around the world, subscribe here to Signal, our daily newsletter. Now, without further ado, the first question is...

More Show less

Subscribe to GZERO Media's newsletter, Signal

GZERO World with Ian Bremmer. Watch episodes now

GZEROMEDIA

Subscribe to GZERO Media's newsletter: Signal

GZERO World with Ian Bremmer. Watch episodes now

GZEROMEDIA

Subscribe to GZERO Media's newsletter: Signal